StockData
Whitehawk Therapeutics, Inc. logo

Whitehawk Therapeutics, Inc. (WHWK) stock

WHWKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$3.13+0.05 (+1.62%)

Close on Nov 18, 2026Market cap $178.44MP/E –Yield –

Whitehawk Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Whitehawk Therapeutics's total assets was $193.99M at Jun 30, 2026. For fiscal 2025 it was $150.83M, up 114.5% from the year before. Over ten years it grew 146.1% a year on average. The highest annual figure on record is $184.24M in fiscal 2022.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$150.83M+114.5%
FY2024Dec 31, 2024$70.32M-46.9%
FY2023Dec 31, 2023$132.42M-28.1%
FY2022Dec 31, 2022$184.24M+16.7%
FY2021Dec 31, 2021$157.91M+738.8%
FY2020Dec 31, 2020$18.83M-52.9%
FY2019Dec 31, 2019$39.94M-37.7%
FY2018Dec 31, 2018$64.12M+204.9%
FY2017Dec 31, 2017$21.03M+777.3%
FY2016Dec 31, 2016$2.40M+12835.8%
FY2015Dec 31, 2015$18.53K+252.1%
FY2014Dec 31, 2014$5.26K-40.1%
FY2013Dec 31, 2013$8.78K+8.3%
FY2012Dec 31, 2012$8.11K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$193.99M+7.3%
Q1 FY2026Mar 31, 2026$127.23M-45.6%
Q4 FY2025Dec 31, 2025$150.83M+114.5%
Q3 FY2025Sep 30, 2025$167.02M+94.9%
Q2 FY2025Jun 30, 2025$180.82M+77.9%
Q1 FY2025Mar 31, 2025$234.00M+110.7%
Q4 FY2024Dec 31, 2024$70.32M-46.9%
Q3 FY2024Sep 30, 2024$85.70M-38.6%
Q2 FY2024Jun 30, 2024$101.62M-32.8%
Q1 FY2024Mar 31, 2024$111.07M-34.9%
Q4 FY2023Dec 31, 2023$132.42M-28.1%
Q3 FY2023Sep 30, 2023$139.66M-28.0%
Q2 FY2023Jun 30, 2023$151.23M+17.6%
Q1 FY2023Mar 31, 2023$170.65M+19.9%
Q4 FY2022Dec 31, 2022$184.24M+16.7%
Q3 FY2022Sep 30, 2022$194.10M+15.0%
Q2 FY2022Jun 30, 2022$128.64M+243.7%
Q1 FY2022Mar 31, 2022$142.32M+245.8%
Q4 FY2021Dec 31, 2021$157.91M+738.8%
Q3 FY2021Sep 30, 2021$168.77M+238.7%
Q2 FY2021Jun 30, 2021$37.42M-18.1%
Q1 FY2021Mar 31, 2021$41.16M+15.3%
Q4 FY2020Dec 31, 2020$18.83M-52.9%
Q3 FY2020Sep 30, 2020$49.83M+9.4%
Q2 FY2020Jun 30, 2020$45.72M-7.8%
Q1 FY2020Mar 31, 2020$35.70M-35.2%
Q4 FY2019Dec 31, 2019$39.94M-37.7%
Q3 FY2019Sep 30, 2019$45.55M-35.1%
Q2 FY2019Jun 30, 2019$49.60M-28.7%
Q1 FY2019Mar 31, 2019$55.06M+273.7%
Q4 FY2018Dec 31, 2018$64.12M+204.9%
Q3 FY2018Sep 30, 2018$70.16M+169.8%
Q2 FY2018Jun 30, 2018$69.54M+133.4%
Q1 FY2018Mar 31, 2018$14.73M-59.4%
Q4 FY2017Dec 31, 2017$21.03M+777.3%
Q3 FY2017Sep 30, 2017$26.00M+331680.1%
Q2 FY2017Jun 30, 2017$29.79M–
Q1 FY2017Mar 31, 2017$36.28M–
Q4 FY2016Dec 31, 2016$2.40M–
Q3 FY2016Sep 30, 2016$7.84K–

More Whitehawk Therapeutics figures

See a number that looks wrong?